Literature DB >> 20087648

Socioeconomic disparities in the decline in invasive breast cancer incidence.

Brian L Sprague1, Amy Trentham-Dietz, Elizabeth S Burnside.   

Abstract

Breast cancer incidence in the United States has declined dramatically since the year 2002. To improve our understanding of the underlying factors driving breast cancer trends, we explored potential socioeconomic disparities in the recent decline in incidence. We examined the decline in breast cancer incidence according to county-level socioeconomic indicators using data from the Surveillance, Epidemiology and End Results (SEER) program. Since socioeconomic status is associated with mammography screening, we also examined the relation between incidence of ductal carcinoma in situ (DCIS; a strong marker of mammography utilization) and the decline in invasive breast cancer. The reduction in invasive breast cancer incidence between 1998-2001 and 2003-2006 in the SEER 9 registries was greatest among women living in counties with higher median household income (-16% change for > or = $85,000 vs. -4% for <$35,000; P(trend) < 0.01) and a higher percentage of adults aged 25 years or older with a bachelor's degree (-13% change for > or = 40% vs. -8% for <15%; P(trend) < 0.01). Counties with higher DCIS incidence during 1985-2001 had a larger decrease in invasive breast cancer incidence (absolute decrease 1.7 percentage points greater per 5 per 100,000 increase in DCIS incidence; P = 0.01). This association was present for both ER-positive and ER-negative invasive cancers (P < 0.05). In summary, the decline in breast cancer incidence has been largest in areas with high socioeconomic status and high screening utilization rates. These results are consistent with the hypothesis that a saturation of screening mammography utilization contributed to the overall decline in breast cancer incidence.

Entities:  

Mesh:

Year:  2010        PMID: 20087648      PMCID: PMC2904433          DOI: 10.1007/s10549-010-0737-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

1.  Breast carcinoma in situ: risk factors and screening patterns.

Authors:  E B Claus; M Stowe; D Carter
Journal:  J Natl Cancer Inst       Date:  2001-12-05       Impact factor: 13.506

2.  Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.

Authors:  R K Ross; A Paganini-Hill; P C Wan; M C Pike
Journal:  J Natl Cancer Inst       Date:  2000-02-16       Impact factor: 13.506

3.  Risk factors for carcinoma in situ of the breast.

Authors:  A Trentham-Dietz; P A Newcomb; B E Storer; P L Remington
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-07       Impact factor: 4.254

4.  Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects.

Authors:  Stephanie A Robert; Indiana Strombom; Amy Trentham-Dietz; John M Hampton; Jane A McElroy; Polly A Newcomb; Patrick L Remington
Journal:  Epidemiology       Date:  2004-07       Impact factor: 4.822

5.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

6.  The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994.

Authors:  Diana Friedman-Koss; Carlos J Crespo; Michele F Bellantoni; Ross E Andersen
Journal:  Menopause       Date:  2002 Jul-Aug       Impact factor: 2.953

7.  Recent incidence trends for breast cancer in women and the relevance of early detection: an update.

Authors:  B A Miller; E J Feuer; B F Hankey
Journal:  CA Cancer J Clin       Date:  1993 Jan-Feb       Impact factor: 508.702

8.  Association of breast cancer and cervical cancer incidence with income and education among whites and blacks.

Authors:  S S Devesa; E L Diamond
Journal:  J Natl Cancer Inst       Date:  1980-09       Impact factor: 13.506

9.  Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004.

Authors:  Christopher I Li; Janet R Daling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

10.  Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.

Authors:  Karla Kerlikowske; Diana L Miglioretti; Rachel Ballard-Barbash; Donald L Weaver; Diana S M Buist; William E Barlow; Gary Cutter; Berta M Geller; Bonnie Yankaskas; Stephen H Taplin; Patricia A Carney
Journal:  J Clin Oncol       Date:  2003-12-01       Impact factor: 44.544

View more
  9 in total

1.  Incidence of breast cancer in the United States: current and future trends.

Authors:  William F Anderson; Hormuzd A Katki; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2011-07-13       Impact factor: 13.506

2.  Increased mortality among Hispanic testis cancer patients independent of neighborhood socioeconomic status: a SEER study.

Authors:  Timothy V Johnson; Wayland Hsiao; Ashesh Jani; Viraj A Master
Journal:  J Immigr Minor Health       Date:  2011-10

3.  Job Authority and Breast Cancer.

Authors:  Tetyana Pudrovska
Journal:  Soc Forces       Date:  2013

4.  Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance.

Authors:  Carlos Chavez de Paz Villanueva; Valentina Bonev; Maheswari Senthil; Naveenraj Solomon; Mark E Reeves; Carlos A Garberoglio; Jukes P Namm; Sharon S Lum
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

5.  Higher-status occupations and breast cancer: a life-course stress approach.

Authors:  Tetyana Pudrovska; Deborah Carr; Michael McFarland; Caitlyn Collins
Journal:  Soc Sci Med       Date:  2013-04-24       Impact factor: 4.634

6.  Partnership Status and Socioeconomic Factors in Relation to Health Behavior Changes after a Diagnosis of Ductal Carcinoma In Situ.

Authors:  Sherrie Khadanga; Susan G Lakoski; Vicki Hart; Brian L Sprague; Yi Ba; John M Hampton; Stephen T Higgins; Philip A Ades; Polly A Newcomb; Amy Trentham-Dietz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-06       Impact factor: 4.254

7.  Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.

Authors:  A Waldmann; S Nolte; M A Weinstock; E W Breitbart; N Eisemann; A C Geller; R Greinert; B Volkmer; A Katalinic
Journal:  Br J Cancer       Date:  2012-01-31       Impact factor: 7.640

8.  Expression pattern and methylation of estrogen receptor α in breast intraductal proliferative lesions.

Authors:  Xiaoyun Mao; Zhen Qiao; Chuifeng Fan; Ayao Guo; Xinmiao Yu; Feng Jin
Journal:  Oncol Rep       Date:  2016-08-01       Impact factor: 3.906

9.  Time trends in breast cancer incidence and mortality in a mid-sized northeastern Brazilian city.

Authors:  Carlos Anselmo Lima; Margareth Rose Uchoa Rangel; Matheus Macedo-Lima; Angela Maria da Silva
Journal:  BMC Public Health       Date:  2012-10-19       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.